Hepatic drug clearance (HDC) plays a fundamental role in the metabolism and disposition of xenobiotics. Numerous methods of assessing HDC have been proposed in an effort to elucidate the genetic and extra-genetic effects upon xenobiotic biotransformation. One such method incorporates the co-administration of three model compounds to assess three unique parameters of HDC; namely, hepatic blood flow, Phase I (microsomal-mediated oxidative) metabolism, and Phase II (synthesis/conjugation) reactions. Pharmacokinetic studies of indocyanine green, antipyrine, and lorazepam were undertaken to assess each HDC parameter, respectively. This method was utilized to define differences in HDC between normal, healthy, young males and an older group with cancer.
| Identifer | oai:union.ndltd.org:arizona.edu/oai:arizona.openrepository.com:10150/277876 |
| Date | January 1991 |
| Creators | McCloskey, Thomas Michael, 1958- |
| Contributors | Alberts, David S. |
| Publisher | The University of Arizona. |
| Source Sets | University of Arizona |
| Language | en_US |
| Detected Language | English |
| Type | text, Thesis-Reproduction (electronic) |
| Rights | Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. |
Page generated in 0.0016 seconds